ad image

Company Info

Abbott

Abbott

Drug Discovery & Development

Overview

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 107,000 colleagues serve people in more than 160 countries.
Abbott
Contributions
18 Contributions1 / 1
Abbott
Announcement

Abbott Opens State-of-the-Art Global Manufacturing Facility in Kilkenny, Ireland

Abbott

PR-11-24-NI-108Nov 19, 2024
Abbott
Clinical Trial

Abbott Initiates New Clinical Trial to Improve Outcomes in Patients with Advanced Heart Failure

Abbott

PR-10-24-NI-61Oct 25, 2024
Abbott

Abbott Receives FDA Emergency Use Authorization for its COVID-19 Blood Test

Abbott

PA1221Oct 16, 2020
Abbott
FDA Authorization

Abbot Receives FDA Authorization for COVID-19 Antibody Blood Test System

Abbott

PR-M05-20-NI-023May 15, 2020
Abbott
Insulin Delivery

Abbott and Insulet Partner to Integrate Next-Generation Glucose Sensing and Automated Insulin Delivery Technologies for Seamless Diabetes Care

Abbott

PR-M02-20-NI-043Feb 27, 2020
Abbott
Prequalification Approval

Abbott Receives WHO Prequalification Approval for Breakthrough HIV Point-of-Care Test

Abbott

PR-M05-19-NI-017May 06, 2019
Abbott
FDA

FDA Approves World's First Device for Treatment of Premature Babies and Newborns with an Opening in Their Hearts (a Common Congenital Defect)

Abbott

PR-M01-19-NI-048Jan 17, 2019
Abbott
Partnership

Abbott and "Malaria No More" Work Together to End Malaria in Odisha, India

Abbott

PR-M01-19-NI-039Jan 14, 2019
Abbott
Presentation

Abbott to Present at J.P. Morgan Healthcare Conference

Abbott

PR-M12-18-NI-051Dec 14, 2018
Abbott

New Approvals Allow Chronic Pain Sufferers to Try Abbott's Non-Opioid Pain Therapy Before Getting Device Implant

Abbott

PA3370Nov 20, 2018
Abbott
Influenza

Abbott Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results

Abbott

PR-M10-18-NI-099Oct 29, 2018
Abbott
FDA Approval

Abbott's HeartMate 3 Heart Pump Now FDA Approved for Advanced Heart Failure Patients Not Eligible for a Heart Transplant

Abbott

PR-M10-18-NI-072Oct 22, 2018
Abbott
Clinical Data

One-Year Results from Real-World Study Showed Abbott's Portico™ Transcatheter Aortic Valve Safely and Successfully Reduced Severe Aortic Stenosis

Abbott

PR-M10-18-NI-003Oct 01, 2018
Abbott
FDA Approval

Abbott Receives FDA Approval for Next-Generation MitraClip® Device to Treat People with Leaky Heart Valves

Abbott

PR-M07-18-NI-045Jul 13, 2018
Abbott
Innovation

Abbott's MitraClip Therapy Receives National Reimbursement in Japan to Treat Patients with Mitral Regurgitation

Abbott

PR-M03-18-NI-077Mar 22, 2018
Abbott
Clinical Data

New Long-Term Data Show Improved Survival and Lower Rates of Stroke and Pump Thrombosis for Abbott's HeartMate 3 Heart Pump

Abbott

PR-M03-18-NI-053-4552Mar 14, 2018
Abbott

Abbott and Surmodics Announce Agreement for Next-Generation Drug-Coated Balloon

Abbott

PR-M03-18-NI-003Mar 01, 2018
Abbott
Innovation

New FDA MR-Conditional Labeling Approvals Further Expand Abbott's Portfolio of MRI-Ready Devices

Abbott

PR-M01-18-NI-008Jan 03, 2018
1 / 1
0 Contributors1 / 0

No authors found

1 / 0